| Literature DB >> 29879789 |
Matteo Formica1, Andrea Zanirato1, Luca Cavagnaro1, Marco Basso1, Stefano Divano1, Carlo Formica2, Lamberto Felli1.
Abstract
Osteonecrosis (ON) is a clinical entity characterized by a pattern of cell death and complex process of bone resorption and formation. Studies related to ON have largely focused on certain anatomical sites; however, the evidence on vertebral body ON (VBON) is largely inconsistent and fragmented. The aim of this study was to clarify the pathophysiology, risk factors, imaging findings, and available treatment modalities for VBON. A systematic review of the relevant articles published in English was performed using PubMed, Embase, Medline, Google Scholar, Cochrane Central Register of Controlled Trials (CENTRAL), and CINAHL databases. A total of 81 articles were included in this study. Three main topics about VBON were identified: (1) pathophysiology and risk factors, (2) diagnosis, and (3) treatment. Forty-five studies were based on the pathophysiology, 52 on diagnosis, and 38 on the treatment options for VBON. The literature on VBON was limited and mainly focused on post-traumatic cases with a considerable overlap with nonunion and pseudoarthrosis.Entities:
Keywords: Bone necrosis; Diagnosis; Outcomes; Spine; Treatment; Vertebral body
Year: 2018 PMID: 29879789 PMCID: PMC6002160 DOI: 10.4184/asj.2018.12.3.586
Source DB: PubMed Journal: Asian Spine J ISSN: 1976-1902
Fig. 1.The PRISMA (preferred reporting items for systematic review and meta-analysis) 2009 flow diagram illustrating the review process.
Risk factors for vertebral body osteonecrosis reported in the literature
| Risk factors | References |
|---|---|
| Diabetes | Maheshwari et al. [ |
| Diabetes and hypothyroidism | Ma et al. [ |
| Gaucher disease type 1 | Hermann et al. [ |
| Human immunodeficiency virus/highly active anti-retroviral therapy | Sifuentes Giraldo et al. [ |
| Osteopenia/osteoporosis | Kim et al. [ |
| Osteoporosis and chemotherapy | Javier et al. [ |
| Osteoporosis, dermatomyositis, and azathiprine | Martin-Esteve et al. [ |
| Osteoporosis and rheumatic diseases | Modena et al. [ |
| Pancreatitis | Allen et al. [ |
| Renal disease | Nickell et al. [ |
| Sarcoidosis | Ito et al. [ |
| Steroid intake | Wang et al. [ |
| Steroid intake and temporal arteritis | Van Eenenaam and el-Khoury [ |
Accuracy of imaging findings reported in the literature
| Variable | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | LR+ (95% CI) | LR− (95% CI) | DOR (95% CI) | Reference |
|---|---|---|---|---|---|---|---|---|
| IVC (computed tomography) | 85% | 99% | 91% | - | - | - | - | Libicher et al. [ |
| IVC (MRI) | 50% (23%–77%) | 67% (22%–96%) | 78% (40%–96%) | 36% (12%–68%) | 1.5 (0.43–5.22) | 0.75 (0.34–1.62) | 2 (0.3–14.7) | Lin et al. [ |
| Fluid sign (MRI) | 86% (57%–98%) | 100% (54%–100%) | 100% (70%–100%) | 75% (36%–96%) | 11.7 (0.8–170.3) | 0.18 (0.06–0.57) | 65 (2.7–1564) | Lin et al. [ |
CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; LR+, positive likelihood ratio; LR−, negative likelihood ratio; DOR, diagnostic odds ratio; IVC, intravertebral vacuum cleft; MRI, magnetic resonance imaging.
Proposal of novel VBON classification according to relevant imaging findings and sagittal biomechanical parameters
| Variable | VBON classification [ |
|---|---|
| Stage | |
| Stage 0 | Findings: no |
| Diagnostic techniques: X-ray, CT, bone scan, and MRI (negative) | |
| Stage 1 | Findings: edema |
| Diagnostic techniques: X-ray and CT (negative); bone scan and MRI (positive) | |
| Stage 2 | Findings: fluid sign, vacuum sign, double-line sign |
| Diagnostic techniques: X-ray, CT, bone scan, and MRI (positive) | |
| Stage 3 | Findings: fixed deformity |
| Diagnostic techniques: bone scan and MRI (negative); X-ray and CT (positive) | |
| Modifiers[ | |
| Angular kyphosis | |
| A | Anterior/posterior wall height ratio >75% |
| B | Anterior/posterior wall height ratio <75% |
| Sagittal balance[ | |
| 1 | SVA <50 mm; PT ≤thPT[ |
| 2 | SVA <50 mm; PT >thPT |
| 3 | SVA >50 mm; PT >thPT |
General rule: stage+angular kyphosis modifier+sagittal balance modifier=classification (i.e., stages 2, A, 1).
VBON, vertebral body osteonecrosis; CT, computed tomography; MRI, magnetic resonance imaging; SVA, sacral vertical axis; PT, pelvic tilt; thPT, theoretical pelvic tilt.
Modifiers are not applicable for stage 0 and 1.
1, balance; 2, hidden imbalance; 3, imbalance.
thPT=−7+0.37×pelvic incidence; according to Vialle formula [74].
Summary of the main surgical treatment options and related findings
| Surgical technique | Main findings | Reference | Level of evidence |
|---|---|---|---|
| Vertebroplasty | An effective treatment option | Do et al. [ | IV |
| Hirsch et al. [ | V | ||
| Jang et al. [ | IV | ||
| Kim et al. [ | III | ||
| Kim et al. [ | IV | ||
| Peh et al. [ | IV | ||
| Risk of cement leakage in vertebral body osteonecrosis | Cho et al. [ | V | |
| Ha et al. [ | III | ||
| Nieuwenhuijse et al. [ | IV | ||
| IVC and lower risk of cement leakage | Krauss et al. [ | III | |
| Treatment option but associated with recurrent kyphosis | Fang et al. [ | IV | |
| Heo et al. [ | IV | ||
| Similar incidence of cement leakage with and without IVC | Jung et al. [ | III | |
| Tanigawa et al. [ | IV | ||
| Kyphoplasty | An effective treatment option | Chen et al. [ | IV |
| Huang et al. [ | IV | ||
| Yang et al. [ | IV | ||
| Fluid sign related to better kyphosis correction than vacuum sign | Niu et al. [ | III | |
| Vertebroplasty vs. kyphoplasty | Similar incidence of cement leakage | Wu et al. [ | IV |
| Similar clinical and radiological results | Zhang et al. [ | III | |
| Vertebroplasty+short segmental fixation | Treatment option | Lee et al. [ | IV |
| Li et al. [ | IV | ||
| Zhang et al. [ | IV | ||
| Vertebroplasty+posterior fixation with bone cementaugmented screws | Treatment option | Kim and Kim [ | V |
| Kyphoplasty vs. vertebroplasty+short segmental fixation | Similar results | Chen et al. [ | III |
| Intracorporal bone graft+posterior fixation | Effective treatment | Chen et al. [ | IV |
| Treatment option but associated with recurrent kyphosis | Lee et al. [ | IV | |
| Posterior fixation with bone cement-augmented screws | Effective treatment option | Park et al. [ | IV |
| Vertebral column resection+posterior fixation | Treatment option | Lee et al. [ | V |
| Transpedicular subtraction and disc osteotomy+long segment fixation | Treatment option | Zhang et al. [ | IV |
IVC, intravertebral vacuum cleft.
Fig. 2.(A, B) X-ray image of an 81-year-old male patient after 5 months of brace treatment for A1 ASIA (American Spinal Injury As- American Spinal Injury As American Spinal Injury Association) E L2 vertebral fracture staged as 2, A, 3 according to our classification. The image shows intravertebral vacuum cleft compatible with vertebral body osteonecrosis. The patient suffered from uncontrolled back pain with significantly impaired quality of life.
Fig. 3.(A–C) Intraoperative images during vertebral augmentation. For high perioperative risk (American Society of Anesthesiologists 5), the surgeon opted for a bilateral transpedicular percutaneous craniocaudal expandable device to restore the original vertebral shape and bone cement injection to stabilize the reduction.
Fig. 4.(A, B) Postoperative X-rays. The patient reported pain relief and improvement in the quality of life.
Fig. 5.(A) X-ray image at emergency department admission of a 70-year-old male misdiagnosed with A3 ASIA (American Spinal In- ASIA (American Spinal In- (American Spinal In- American Spinal In American Spinal Injury Association) E L1 vertebral fracture. (B, C) X-ray images after 2 months of bracing treatment.
Fig. 6.(A, B) Computed tomography at 2 months after trauma con omputed tomography at 2 months after trauma confirmed severe L1 vertebral body collapse (type A3) with vertebral body osteonecrosis and intravertebral vacuum cleft sign. (C) Magnetic resonance imaging T2-weighted image shows hypointense lesion at L1 vertebral body
Fig. 7.(A–C) X-ray image after corpectomy at the vertebral body osteonecrosis level and posterior fusion (T11–L3).